CN105087788A - 一种分选人细胞的免疫磁珠、其制备及切除方法 - Google Patents
一种分选人细胞的免疫磁珠、其制备及切除方法 Download PDFInfo
- Publication number
- CN105087788A CN105087788A CN201510481064.2A CN201510481064A CN105087788A CN 105087788 A CN105087788 A CN 105087788A CN 201510481064 A CN201510481064 A CN 201510481064A CN 105087788 A CN105087788 A CN 105087788A
- Authority
- CN
- China
- Prior art keywords
- nucleic acid
- magnetic bead
- cell
- antibody
- antibody complex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000011324 bead Substances 0.000 title claims abstract description 107
- 238000000034 method Methods 0.000 title claims abstract description 38
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 210000005260 human cell Anatomy 0.000 title abstract 2
- 210000004027 cell Anatomy 0.000 claims abstract description 130
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 61
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 58
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 58
- 239000000427 antigen Substances 0.000 claims abstract description 13
- 102000036639 antigens Human genes 0.000 claims abstract description 13
- 108091007433 antigens Proteins 0.000 claims abstract description 13
- 102000004190 Enzymes Human genes 0.000 claims description 38
- 108090000790 Enzymes Proteins 0.000 claims description 38
- 230000008878 coupling Effects 0.000 claims description 30
- 238000010168 coupling process Methods 0.000 claims description 30
- 238000005859 coupling reaction Methods 0.000 claims description 30
- 108091008146 restriction endonucleases Proteins 0.000 claims description 30
- 239000007822 coupling agent Substances 0.000 claims description 27
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 26
- 239000006228 supernatant Substances 0.000 claims description 20
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical group O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 16
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 claims description 12
- 238000012360 testing method Methods 0.000 claims description 11
- 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 claims description 10
- 238000013016 damping Methods 0.000 claims description 10
- 239000012530 fluid Substances 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 8
- 230000012447 hatching Effects 0.000 claims description 7
- 210000004698 lymphocyte Anatomy 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 7
- 239000002245 particle Substances 0.000 claims description 7
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 claims description 6
- 101710163270 Nuclease Proteins 0.000 claims description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 5
- 210000004976 peripheral blood cell Anatomy 0.000 claims description 5
- 210000004881 tumor cell Anatomy 0.000 claims description 5
- 210000000222 eosinocyte Anatomy 0.000 claims description 4
- 210000003714 granulocyte Anatomy 0.000 claims description 4
- 210000003958 hematopoietic stem cell Anatomy 0.000 claims description 4
- 210000001178 neural stem cell Anatomy 0.000 claims description 4
- 210000004493 neutrocyte Anatomy 0.000 claims description 4
- 229940104302 cytosine Drugs 0.000 claims description 3
- 125000000524 functional group Chemical group 0.000 claims description 3
- 239000011782 vitamin Substances 0.000 claims description 3
- 229940088594 vitamin Drugs 0.000 claims description 3
- 229930003231 vitamin Natural products 0.000 claims description 3
- 235000013343 vitamin Nutrition 0.000 claims description 3
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 3
- 102000015612 Complement 3b Receptors Human genes 0.000 claims description 2
- 108010024114 Complement 3b Receptors Proteins 0.000 claims description 2
- 108020004414 DNA Proteins 0.000 claims description 2
- 102000053602 DNA Human genes 0.000 claims description 2
- 108010013709 Leukocyte Common Antigens Proteins 0.000 claims description 2
- 102000017095 Leukocyte Common Antigens Human genes 0.000 claims description 2
- 108010031801 Lipopolysaccharide Receptors Proteins 0.000 claims description 2
- 125000003368 amide group Chemical group 0.000 claims description 2
- 210000005105 peripheral blood lymphocyte Anatomy 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 abstract 5
- 238000001976 enzyme digestion Methods 0.000 abstract 1
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 13
- 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 description 8
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 7
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 7
- 206010028980 Neoplasm Diseases 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 description 5
- 108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 108010042407 Endonucleases Proteins 0.000 description 4
- 102000004533 Endonucleases Human genes 0.000 description 4
- 238000001815 biotherapy Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000002773 nucleotide Substances 0.000 description 4
- 125000003729 nucleotide group Chemical group 0.000 description 4
- 230000003139 buffering effect Effects 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000006249 magnetic particle Substances 0.000 description 2
- 210000001616 monocyte Anatomy 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229920001917 Ficoll Polymers 0.000 description 1
- 101000581981 Homo sapiens Neural cell adhesion molecule 1 Proteins 0.000 description 1
- 101000716102 Homo sapiens T-cell surface glycoprotein CD4 Proteins 0.000 description 1
- 101000946843 Homo sapiens T-cell surface glycoprotein CD8 alpha chain Proteins 0.000 description 1
- 102100027347 Neural cell adhesion molecule 1 Human genes 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 1
- 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 description 1
- 102100034922 T-cell surface glycoprotein CD8 alpha chain Human genes 0.000 description 1
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical group [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- -1 aldehyde radical Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000012930 cell culture fluid Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000000975 co-precipitation Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 210000004405 cytokine-induced killer cell Anatomy 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000000432 density-gradient centrifugation Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000000713 high-energy ball milling Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000002923 metal particle Substances 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- 210000005087 mononuclear cell Anatomy 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000004565 tumor cell growth Effects 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6804—Nucleic acid analysis using immunogens
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510481064.2A CN105087788B (zh) | 2015-08-03 | 2015-08-03 | 一种分选人细胞的免疫磁珠、其制备及切除方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510481064.2A CN105087788B (zh) | 2015-08-03 | 2015-08-03 | 一种分选人细胞的免疫磁珠、其制备及切除方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105087788A true CN105087788A (zh) | 2015-11-25 |
CN105087788B CN105087788B (zh) | 2018-11-23 |
Family
ID=54569114
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510481064.2A Active CN105087788B (zh) | 2015-08-03 | 2015-08-03 | 一种分选人细胞的免疫磁珠、其制备及切除方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105087788B (zh) |
Cited By (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105606795A (zh) * | 2015-12-31 | 2016-05-25 | 上海白泽医疗器械有限公司 | 一种细胞免疫磁珠分选系统 |
WO2016086861A1 (zh) * | 2014-12-05 | 2016-06-09 | 赛业(苏州)生物科技有限公司 | 基于核酸内切酶特异性识别的细胞分选系统、方法及用途 |
CN105695326A (zh) * | 2016-03-14 | 2016-06-22 | 海狸纳米科技(苏州)有限公司 | 一种细胞特异性分选体系和细胞特异性分选方法 |
CN106366194A (zh) * | 2016-08-26 | 2017-02-01 | 上海交通大学 | 一种用于外周血淋巴细胞分离的免疫磁珠及其制备与应用 |
WO2017192760A1 (en) * | 2016-05-03 | 2017-11-09 | Flodesign Sonics, Inc. | Therapeutic cell washing, concentration, and separation utilizing acoustophoresis |
US10308928B2 (en) | 2013-09-13 | 2019-06-04 | Flodesign Sonics, Inc. | System for generating high concentration factors for low cell density suspensions |
WO2019129178A1 (zh) * | 2017-12-29 | 2019-07-04 | 上海白泽医学检验所有限公司 | 一种含抗cd45单抗的组合物及其使用方法 |
US10662402B2 (en) | 2012-03-15 | 2020-05-26 | Flodesign Sonics, Inc. | Acoustic perfusion devices |
US10689609B2 (en) | 2012-03-15 | 2020-06-23 | Flodesign Sonics, Inc. | Acoustic bioreactor processes |
US10704021B2 (en) | 2012-03-15 | 2020-07-07 | Flodesign Sonics, Inc. | Acoustic perfusion devices |
US10724029B2 (en) | 2012-03-15 | 2020-07-28 | Flodesign Sonics, Inc. | Acoustophoretic separation technology using multi-dimensional standing waves |
US10737953B2 (en) | 2012-04-20 | 2020-08-11 | Flodesign Sonics, Inc. | Acoustophoretic method for use in bioreactors |
US10785574B2 (en) | 2017-12-14 | 2020-09-22 | Flodesign Sonics, Inc. | Acoustic transducer driver and controller |
US10814253B2 (en) | 2014-07-02 | 2020-10-27 | Flodesign Sonics, Inc. | Large scale acoustic separation device |
US10947493B2 (en) | 2012-03-15 | 2021-03-16 | Flodesign Sonics, Inc. | Acoustic perfusion devices |
US10967298B2 (en) | 2012-03-15 | 2021-04-06 | Flodesign Sonics, Inc. | Driver and control for variable impedence load |
US10975368B2 (en) | 2014-01-08 | 2021-04-13 | Flodesign Sonics, Inc. | Acoustophoresis device with dual acoustophoretic chamber |
CN112774645A (zh) * | 2020-12-25 | 2021-05-11 | 浙江康佰裕生物科技有限公司 | 一种作为人工抗原呈递细胞的磷脂微珠及其制备方法及其用途 |
US11007457B2 (en) | 2012-03-15 | 2021-05-18 | Flodesign Sonics, Inc. | Electronic configuration and control for acoustic standing wave generation |
US11021699B2 (en) | 2015-04-29 | 2021-06-01 | FioDesign Sonics, Inc. | Separation using angled acoustic waves |
US11085035B2 (en) | 2016-05-03 | 2021-08-10 | Flodesign Sonics, Inc. | Therapeutic cell washing, concentration, and separation utilizing acoustophoresis |
CN113281137A (zh) * | 2021-02-26 | 2021-08-20 | 中国计量科学研究院 | 免疫磁珠富集后的细菌待检测样品的磁珠去除方法 |
US11214789B2 (en) | 2016-05-03 | 2022-01-04 | Flodesign Sonics, Inc. | Concentration and washing of particles with acoustics |
US11377651B2 (en) | 2016-10-19 | 2022-07-05 | Flodesign Sonics, Inc. | Cell therapy processes utilizing acoustophoresis |
US11420136B2 (en) | 2016-10-19 | 2022-08-23 | Flodesign Sonics, Inc. | Affinity cell extraction by acoustics |
US11459540B2 (en) | 2015-07-28 | 2022-10-04 | Flodesign Sonics, Inc. | Expanded bed affinity selection |
US11474085B2 (en) | 2015-07-28 | 2022-10-18 | Flodesign Sonics, Inc. | Expanded bed affinity selection |
US11708572B2 (en) | 2015-04-29 | 2023-07-25 | Flodesign Sonics, Inc. | Acoustic cell separation techniques and processes |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101892196A (zh) * | 2010-07-14 | 2010-11-24 | 北京大学 | 一种细胞分选磁珠及合成方法以及其在细胞分选中的应用 |
CN104450617A (zh) * | 2014-12-05 | 2015-03-25 | 赛业(苏州)生物科技有限公司 | 基于核酸内切酶特异性识别的细胞分选系统的应用 |
CN104498595A (zh) * | 2014-12-05 | 2015-04-08 | 赛业(苏州)生物科技有限公司 | 基于核酸内切酶特异性识别的细胞分选系统 |
-
2015
- 2015-08-03 CN CN201510481064.2A patent/CN105087788B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101892196A (zh) * | 2010-07-14 | 2010-11-24 | 北京大学 | 一种细胞分选磁珠及合成方法以及其在细胞分选中的应用 |
CN104450617A (zh) * | 2014-12-05 | 2015-03-25 | 赛业(苏州)生物科技有限公司 | 基于核酸内切酶特异性识别的细胞分选系统的应用 |
CN104498595A (zh) * | 2014-12-05 | 2015-04-08 | 赛业(苏州)生物科技有限公司 | 基于核酸内切酶特异性识别的细胞分选系统 |
Non-Patent Citations (2)
Title |
---|
INVITROGEN: "CELLection™ Epithelial Enrich", 《WWW.LIFETECHNOLOGIES.COM》 * |
INVITROGEN: "CELLection™ Pan Mouse IgG Kit", 《WWW.LIFETECHNOLOGIES.COM》 * |
Cited By (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10662402B2 (en) | 2012-03-15 | 2020-05-26 | Flodesign Sonics, Inc. | Acoustic perfusion devices |
US10967298B2 (en) | 2012-03-15 | 2021-04-06 | Flodesign Sonics, Inc. | Driver and control for variable impedence load |
US10947493B2 (en) | 2012-03-15 | 2021-03-16 | Flodesign Sonics, Inc. | Acoustic perfusion devices |
US11007457B2 (en) | 2012-03-15 | 2021-05-18 | Flodesign Sonics, Inc. | Electronic configuration and control for acoustic standing wave generation |
US10724029B2 (en) | 2012-03-15 | 2020-07-28 | Flodesign Sonics, Inc. | Acoustophoretic separation technology using multi-dimensional standing waves |
US10704021B2 (en) | 2012-03-15 | 2020-07-07 | Flodesign Sonics, Inc. | Acoustic perfusion devices |
US10689609B2 (en) | 2012-03-15 | 2020-06-23 | Flodesign Sonics, Inc. | Acoustic bioreactor processes |
US10737953B2 (en) | 2012-04-20 | 2020-08-11 | Flodesign Sonics, Inc. | Acoustophoretic method for use in bioreactors |
US10308928B2 (en) | 2013-09-13 | 2019-06-04 | Flodesign Sonics, Inc. | System for generating high concentration factors for low cell density suspensions |
US10975368B2 (en) | 2014-01-08 | 2021-04-13 | Flodesign Sonics, Inc. | Acoustophoresis device with dual acoustophoretic chamber |
US10814253B2 (en) | 2014-07-02 | 2020-10-27 | Flodesign Sonics, Inc. | Large scale acoustic separation device |
WO2016086861A1 (zh) * | 2014-12-05 | 2016-06-09 | 赛业(苏州)生物科技有限公司 | 基于核酸内切酶特异性识别的细胞分选系统、方法及用途 |
US11708572B2 (en) | 2015-04-29 | 2023-07-25 | Flodesign Sonics, Inc. | Acoustic cell separation techniques and processes |
US11021699B2 (en) | 2015-04-29 | 2021-06-01 | FioDesign Sonics, Inc. | Separation using angled acoustic waves |
US11459540B2 (en) | 2015-07-28 | 2022-10-04 | Flodesign Sonics, Inc. | Expanded bed affinity selection |
US11474085B2 (en) | 2015-07-28 | 2022-10-18 | Flodesign Sonics, Inc. | Expanded bed affinity selection |
CN105606795A (zh) * | 2015-12-31 | 2016-05-25 | 上海白泽医疗器械有限公司 | 一种细胞免疫磁珠分选系统 |
CN105695326A (zh) * | 2016-03-14 | 2016-06-22 | 海狸纳米科技(苏州)有限公司 | 一种细胞特异性分选体系和细胞特异性分选方法 |
US10640760B2 (en) | 2016-05-03 | 2020-05-05 | Flodesign Sonics, Inc. | Therapeutic cell washing, concentration, and separation utilizing acoustophoresis |
US11085035B2 (en) | 2016-05-03 | 2021-08-10 | Flodesign Sonics, Inc. | Therapeutic cell washing, concentration, and separation utilizing acoustophoresis |
US11214789B2 (en) | 2016-05-03 | 2022-01-04 | Flodesign Sonics, Inc. | Concentration and washing of particles with acoustics |
WO2017192760A1 (en) * | 2016-05-03 | 2017-11-09 | Flodesign Sonics, Inc. | Therapeutic cell washing, concentration, and separation utilizing acoustophoresis |
CN106366194A (zh) * | 2016-08-26 | 2017-02-01 | 上海交通大学 | 一种用于外周血淋巴细胞分离的免疫磁珠及其制备与应用 |
US11377651B2 (en) | 2016-10-19 | 2022-07-05 | Flodesign Sonics, Inc. | Cell therapy processes utilizing acoustophoresis |
US11420136B2 (en) | 2016-10-19 | 2022-08-23 | Flodesign Sonics, Inc. | Affinity cell extraction by acoustics |
US10785574B2 (en) | 2017-12-14 | 2020-09-22 | Flodesign Sonics, Inc. | Acoustic transducer driver and controller |
WO2019129178A1 (zh) * | 2017-12-29 | 2019-07-04 | 上海白泽医学检验所有限公司 | 一种含抗cd45单抗的组合物及其使用方法 |
CN112774645A (zh) * | 2020-12-25 | 2021-05-11 | 浙江康佰裕生物科技有限公司 | 一种作为人工抗原呈递细胞的磷脂微珠及其制备方法及其用途 |
CN113281137A (zh) * | 2021-02-26 | 2021-08-20 | 中国计量科学研究院 | 免疫磁珠富集后的细菌待检测样品的磁珠去除方法 |
Also Published As
Publication number | Publication date |
---|---|
CN105087788B (zh) | 2018-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105087788A (zh) | 一种分选人细胞的免疫磁珠、其制备及切除方法 | |
EP3702459B1 (en) | Method for improving fetal hemoglobin expression | |
CN108753817A (zh) | 增强细胞的抗癌能力的方法及采用该方法获得的增强型细胞 | |
US7049072B2 (en) | Gene expression analysis of pluri-differentiated mesenchymal progenitor cells and methods for diagnosing a leukemic disease state | |
CN104894068A (zh) | 一种利用CRISPR/Cas9制备CAR-T细胞的方法 | |
JPH0576354A (ja) | ヒトプロジエニター細胞のサブセツト | |
CN106220736A (zh) | 一种嵌合抗原受体、表达其的细胞及其制备方法和用途 | |
CN115443333A (zh) | 一种基因编辑的造血干细胞及其与car-t细胞的联合应用 | |
Zhang et al. | Single-cell chemokine receptor profiles delineate the immune contexture of tertiary lymphoid structures in head and neck squamous cell carcinoma | |
US20230052157A1 (en) | Method for obtaining nucleic acid for sequencing | |
CN104804092B (zh) | 一种抗b细胞生长刺激因子的纳米抗体及其用途 | |
CN110055219B (zh) | 一种利用非动员外周血制备异质性造血干祖细胞的方法 | |
CN113980143B (zh) | 靶向cd276的嵌合抗原受体、嵌合抗原受体t细胞及制备方法和制药应用 | |
Li et al. | Integrated single-cell transcriptome analysis of the tumor ecosystems underlying cervical cancer metastasis | |
CN114480645B (zh) | 多发性骨髓瘤耗竭性nk细胞亚群、其特征基因及其应用 | |
CN113549597B (zh) | 一种人原发性骨髓纤维化细胞株及其应用 | |
WO2003029432A2 (en) | Human mesenchymal progenitor cell | |
CN112175905B (zh) | 一种高效敲除nk细胞中cd96基因的方法 | |
EP4086341A1 (en) | Method for purifying ucart cell and use thereof | |
CN111849917B (zh) | 一种融合表达ⅰ型il-10受体的第四代car-t细胞及其制备方法与应用 | |
CN104804090B (zh) | 一种抗b细胞生长刺激因子的纳米抗体和用途 | |
CN115404214B (zh) | 甘草酸应用及可体外定向获得免疫细胞的方法 | |
US20200224166A1 (en) | Method for preparing heterogeneous hematopoietic stem and progenitor cells using non-mobilized peripheral blood | |
CN114075548B (zh) | 一种靶向axl的car-t细胞及其制备方法和应用 | |
WO2022267842A1 (en) | Disruptions of pdcd1, adora2a, and ctla4 genes and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20171214 Address after: 201814 Shanghai Jiading District city Anting Town Park Road No. 1585 building 7 floor 3 Applicant after: SHANGHAI BAIZE MEDICAL INSTRUMENT Co.,Ltd. Applicant after: SHANGHAI ENGINEERING RESEARCH CENTER FOR CELL THERAPY GROUP Co.,Ltd. Address before: 201805 Shanghai Jiading District city Anting Town Park Road No. 1585 building 7 floor 3 Applicant before: SHANGHAI BAIZE MEDICAL INSTRUMENT Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder |
Address after: 201814 3rd Floor, 7th Building, 1585 Yuanguo Road, Anting Town, Jiading District, Shanghai Co-patentee after: SHANGHAI CELL THERAPY GROUP Co.,Ltd. Patentee after: SHANGHAI BAIZE MEDICAL INSTRUMENT Co.,Ltd. Address before: 201814 3rd Floor, 7th Building, 1585 Yuanguo Road, Anting Town, Jiading District, Shanghai Co-patentee before: SHANGHAI ENGINEERING RESEARCH CENTER FOR CELL THERAPY GROUP Co.,Ltd. Patentee before: SHANGHAI BAIZE MEDICAL INSTRUMENT Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210114 Address after: Room j216, 4th floor, 4229 Bao'an Road, Jiading District, Shanghai, 201814 Patentee after: SHANGHAI BAIZE MEDICAL INSTRUMENT Co.,Ltd. Patentee after: SHANGHAI CELL THERAPY GROUP Co.,Ltd. Patentee after: Henan cell therapy group Co.,Ltd. Address before: 201814 3rd Floor, 7th Building, 1585 Yuanguo Road, Anting Town, Jiading District, Shanghai Patentee before: SHANGHAI BAIZE MEDICAL INSTRUMENT Co.,Ltd. Patentee before: SHANGHAI CELL THERAPY GROUP Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CP03 | Change of name, title or address |
Address after: Room j216, 4th floor, 4229 Bao'an Road, Jiading District, Shanghai, 201814 Patentee after: SHANGHAI BAIZE MEDICAL INSTRUMENT Co.,Ltd. Country or region after: China Patentee after: Shanghai Cell Therapy Group Co.,Ltd. Patentee after: Henan cell therapy group Co.,Ltd. Address before: Room j216, 4th floor, 4229 Bao'an Road, Jiading District, Shanghai, 201814 Patentee before: SHANGHAI BAIZE MEDICAL INSTRUMENT Co.,Ltd. Country or region before: China Patentee before: SHANGHAI CELL THERAPY GROUP Co.,Ltd. Patentee before: Henan cell therapy group Co.,Ltd. |
|
CP03 | Change of name, title or address |